Brazil ANVISA expands product safety enforcement

Timeline

1. about 9 hours ago

   [HEALTH] 10 sources

   Anvisa bans six types of unregulated salt products in Brazil

   Anvisa has banned and ordered the seizure of six unregulated salt products from the brand Quanqton in Brazil due to clandestine manufacturing and deceptive health claims.

2. 9 days ago

   [HEALTH] 15 sources

   Brazil's Anvisa suspends multiple medical and consumer products over safety concerns

   Anvisa has suspended or recalled dozens of medical, pharmaceutical, food and cosmetic products in Brazil over safety and regulatory violations, affecting manufacturers and consumers nationwide.

3. 11 days ago

   [HEALTH] 55 sources

   Brazil's Anvisa orders recall of Paramol batch and seizes counterfeit Mounjaro

   Anvisa recalled a mold‑contaminated Paramol batch and seized counterfeit Mounjaro units with an illegal serial number, urging consumers to stop use and verify authenticity.

4. 13 days ago

   [HEALTH] 2 sources

   Brazil's Anvisa warns that counterfeit weight‑loss injection pens threaten heart health

   Brazil's Anvisa warns that fake weight‑loss injection pens sold online can cause arrhythmias and heart attacks, urging consumers to avoid unregistered products.

5. 14 days ago

   [HEALTH] 4 sources

   Retatrutida remains unapproved as Brazil seizes over R$11 million of illegal shipments

   Retatrutida, an unapproved experimental obesity drug, was seized by Brazilian authorities in illegal shipments from Paraguay worth over R$11 million in early 2026, highlighting health risks and lack of approval

6. 17 days ago

   [HEALTH] 14 sources

   Brazil's Anvisa warns against illegal retatrutida weight‑loss pens

   Anvisa warns that experimental obesity drug retatrutida, still unapproved worldwide, is being sold illegally in Brazil, with seizures exceeding R$ 11 million in early 2026 and serious health risks.

7. 25 days ago

   [HEALTH] 37 sources

   Brazil's Anvisa recalls Mamba Water batches over contamination

   Brazil's health regulator Anvisa recalled Mamba Water cans (lots 13‑14) after detecting Pseudomonas aeruginosa and suspended all Mister Hemp energy drinks over safety and registration failures.

8. about 1 month ago

   [HEALTH] 2 sources

   Brazil's ANVISA issues new rules on cosmetic ingredient restrictions

   ANVISA released new resolutions restricting and prohibiting certain cosmetic ingredients, opened a public consultation for further restrictions, and continues its broader role regulating health‑related products

9. about 1 month ago

   [HEALTH] 2 sources

   Brazil's Anvisa suspends Dobutamine drug and bans products from five firms

   Anvisa has suspended the dobutamine drug over quality concerns and banned supplements from five firms for safety and registration violations.

10. about 1 month ago

    [HEALTH] 2 sources

    Brazil's Anvisa orders recall of repellent batch and several cosmetics

    Anvisa in Brazil has recalled a repellent batch that failed IR3535 efficacy tests and suspended several DC Biocosméticos cosmetics and all products bearing ATSUM’s label for lacking proper sanitary registration

11. about 1 month ago

    [HEALTH] 11 sources

    Brazil's Anvisa bans digital health platform, recalls repellent, cosmetics and industrial kerosene

    Anvisa shut down the Voy telehealth platform, recalled a faulty Repele repellent batch, blocked unregistered DC Biocosméticos cosmetics, and ordered a nationwide recall of Querosene Petrus cleaning product.

12. about 1 month ago

    [HEALTH] 2 sources

    Anvisa seizes Artro100 supplement and recalls creatine gum batches

    Anvisa seized the Artro100 supplement and recalled Idn Labs' creatine‑gum batches (lots 0061/02/2026, 0367/11/2025, 0012/01/2026) due to composition, labeling and unauthorized health‑claim issues.

13. about 1 month ago

    [HEALTH] 8 sources

    Anvisa bans Voy weight‑loss platform for lacking medical‑software registration

    Anvisa prohibited the Voy obesity‑treatment platform for missing medical‑software registration and pharmacy authorization, warning of unsafe drug sourcing; Voy says it will stay online pending appeal.

14. about 2 months ago

    [HEALTH] 36 sources

    Anvisa bans obesity‑treatment platform Voy and suspends Artro100 supplement and creatine gummies

    Anvisa suspended the Voy obesity‑treatment platform for lacking medical‑device registration and banned the Artro100 supplement and certain creatine‑gum batches due to unknown composition, illegal health claims,

15. about 2 months ago

    [HEALTH] 3 sources

    Brazil's Anvisa Tightens Hair‑Straightening Product Rules

    Anvisa bans formaldehyde and glioxilic acid in hair‑straightening products, enforces registration, and highlights health risks, while France urges EU limits on Brazilian‑style straighteners.

16. about 2 months ago

    [HEALTH] 8 sources

    Anvisa seizes over 25,000 illegal electronic cigarettes in Brazil

    Anvisa and Receita Federal seized over 25,000 illegal e‑cigarettes and 107,000 contraband cigarette packs nationwide, citing health risks to youth and enforcing the ban under RDC 855/2024.

17. about 2 months ago

    [HEALTH] 4 sources

    Brazilian health agencies urge clinics to tighten medical supply storage

    Brazil’s growing medical‑product market is prompting Anvisa and experts to push clinics for better temperature, humidity and documentation controls to keep supplies safe.

18. about 2 months ago

    [HEALTH] 19 sources

    Brazil's Anvisa recalls antibiotics and saline solution over quality defects

    Anvisa recalled two antibiotics—Polycid with a glass fragment and clindamycin with discoloration/particles—and a saline solution due to quality deviations, urging immediate removal from use.

19. 2 months ago

    [HEALTH] 2 sources

    Brazil's Anvisa orders recall of Essentia Pharma infant formula

    Anvisa ordered a nationwide recall of Essentia Pharma infant formula made by HKM Farmácia, citing lack of registration and misleading labels that could endanger infants.

20. 2 months ago

    [HEALTH] 2 sources

    Brazil's Anvisa extends digital prescription deadline and bans three consumer products

    Anvisa delayed its digital prescription system to Sept 30 2026 and banned a Colgate toothbrush, a Sócio Rico perfume and a sodium percarbonate bleach over registration issues.

21. 2 months ago

    [HEALTH] 2 sources

    Brazil's Anvisa suspends medication lots, seizes cosmetics

    Anvisa halted specific hypertension and breast‑cancer drug batches for quality issues and ordered the seizure of unregistered cosmetics, banning their sale and use in Brazil.

22. 3 months ago

    [HEALTH] 8 sources

    Brazil's Anvisa suspends specific statin and dexamethasone batches

    Anvisa halts specific statin and dexamethasone batches over packaging mix‑up and solution issues, also bans unregistered herbal medicines.

This summary has been updated 8 times: see revision history